Bio-Rad offers to acquire all equity interests of Stilla Technology. The acquisition is expected to complement Bio-Rad's existing digital PCR portfolio.

Q4 2024 Earnings Call Transcript February 13, 2025 Bio-Rad Laboratories, Inc. beats earnings expectations. Reported EPS is $2.9, expectations were $2.86. Operator: Thank you for standing by. My name ...

Full Year 2024 Results Key Financial Results Revenue: US$2.57b (down 3.9% from ...

StockNews.com lowered shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a buy rating to a hold rating in a research note issued to investors on Monday morning. Other analysts have also ...

This report describes and explains the liquid biopsy for cancer diagnostics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...

Diagnostics company Bio-Rad has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing biological samples.

Bio-Rad Laboratories is slashing 5% of its staff, including over 100 in its Bay Area hometown, amid struggles in the biotech ...

A diagnostic medical sonographer could be answering the question "Is it a boy or a girl?" as well as a host of other life-changing medical questions with the help of ultrasound technology.

The past decade has seen a dramatic increase in the technology that allows the detection of minute amounts of disease-related analytes in biofluids. This is ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...